nile red staining kit Search Results


lipid fluorescence staining kit (nile red method)  (Beijing Solarbio Science)
90
Beijing Solarbio Science lipid fluorescence staining kit (nile red method)
Lipid Fluorescence Staining Kit (Nile Red Method), supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nile+red+staining+kit/pmc12176760-130-14-21?v=Beijing+Solarbio+Science
Average 90 stars, based on 1 article reviews
lipid fluorescence staining kit (nile red method) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
nile red staining kit  (Beijing Solarbio Science)
90
Beijing Solarbio Science nile red staining kit
Inhibition of CTU2 expression synergizes the anti-tumor effect of T0901317. Nude mice were s.c. injected with shCtrl HepG2 or shCTU2 HepG2 cells (1 × 10 6 cells/mouse). When tumors were visible, mice were divided into 2 groups (Ctrl/T0 group) respectively, which fed normal chow (NC) or normal chow containing T0 [5 mg/day/kg bodyweight (mpk)]. The tumor volumes were measured every other day ( a ). DFI: day following injection. At the end of experiment, mice were sacrificed followed by collecting livers and tumors. Tumors were photographed ( b ), weighed ( c ), and used for other assays. a P < 0.05 vs. shCtrl, b P < 0.05 vs. shCTU2, c P < 0.05 vs . shCtrl + T0, * P < 0.05, ( n = 6); livers were photographed ( d ) and used to determine triglyceride (TG) content ( e ). * P < 0.05, ** P < 0.01, ns: not significant ( n = 4); tumor tissue was used to determine TG levels ( f ), <t>Nile</t> <t>red</t> <t>staining</t> ( g ), FASN immunofluorescent (IF) staining ( h ), and SREBP1, FASN, and ACC1 mRNA levels ( i ). * P < 0.05, ** P < 0.01, *** P < 0.001, ns: not significant, ( n = 4). Two-way ANOVA was performed
Nile Red Staining Kit, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nile+red+staining+kit/pmc11024035-39-5-12?v=Beijing+Solarbio+Science
Average 90 stars, based on 1 article reviews
nile red staining kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
nile red  (Applygen Technologies)
86
Applygen Technologies nile red
Inhibition of CTU2 expression synergizes the anti-tumor effect of T0901317. Nude mice were s.c. injected with shCtrl HepG2 or shCTU2 HepG2 cells (1 × 10 6 cells/mouse). When tumors were visible, mice were divided into 2 groups (Ctrl/T0 group) respectively, which fed normal chow (NC) or normal chow containing T0 [5 mg/day/kg bodyweight (mpk)]. The tumor volumes were measured every other day ( a ). DFI: day following injection. At the end of experiment, mice were sacrificed followed by collecting livers and tumors. Tumors were photographed ( b ), weighed ( c ), and used for other assays. a P < 0.05 vs. shCtrl, b P < 0.05 vs. shCTU2, c P < 0.05 vs . shCtrl + T0, * P < 0.05, ( n = 6); livers were photographed ( d ) and used to determine triglyceride (TG) content ( e ). * P < 0.05, ** P < 0.01, ns: not significant ( n = 4); tumor tissue was used to determine TG levels ( f ), <t>Nile</t> <t>red</t> <t>staining</t> ( g ), FASN immunofluorescent (IF) staining ( h ), and SREBP1, FASN, and ACC1 mRNA levels ( i ). * P < 0.05, ** P < 0.01, *** P < 0.001, ns: not significant, ( n = 4). Two-way ANOVA was performed
Nile Red, supplied by Applygen Technologies, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nile+red+staining+kit/pmc12643874-111-3-5?v=Applygen+Technologies
Average 86 stars, based on 1 article reviews
nile red - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

Image Search Results


Inhibition of CTU2 expression synergizes the anti-tumor effect of T0901317. Nude mice were s.c. injected with shCtrl HepG2 or shCTU2 HepG2 cells (1 × 10 6 cells/mouse). When tumors were visible, mice were divided into 2 groups (Ctrl/T0 group) respectively, which fed normal chow (NC) or normal chow containing T0 [5 mg/day/kg bodyweight (mpk)]. The tumor volumes were measured every other day ( a ). DFI: day following injection. At the end of experiment, mice were sacrificed followed by collecting livers and tumors. Tumors were photographed ( b ), weighed ( c ), and used for other assays. a P < 0.05 vs. shCtrl, b P < 0.05 vs. shCTU2, c P < 0.05 vs . shCtrl + T0, * P < 0.05, ( n = 6); livers were photographed ( d ) and used to determine triglyceride (TG) content ( e ). * P < 0.05, ** P < 0.01, ns: not significant ( n = 4); tumor tissue was used to determine TG levels ( f ), Nile red staining ( g ), FASN immunofluorescent (IF) staining ( h ), and SREBP1, FASN, and ACC1 mRNA levels ( i ). * P < 0.05, ** P < 0.01, *** P < 0.001, ns: not significant, ( n = 4). Two-way ANOVA was performed

Journal: Cell Biology and Toxicology

Article Title: Activation of CTU2 expression by LXR promotes the development of hepatocellular carcinoma

doi: 10.1007/s10565-024-09862-9

Figure Lengend Snippet: Inhibition of CTU2 expression synergizes the anti-tumor effect of T0901317. Nude mice were s.c. injected with shCtrl HepG2 or shCTU2 HepG2 cells (1 × 10 6 cells/mouse). When tumors were visible, mice were divided into 2 groups (Ctrl/T0 group) respectively, which fed normal chow (NC) or normal chow containing T0 [5 mg/day/kg bodyweight (mpk)]. The tumor volumes were measured every other day ( a ). DFI: day following injection. At the end of experiment, mice were sacrificed followed by collecting livers and tumors. Tumors were photographed ( b ), weighed ( c ), and used for other assays. a P < 0.05 vs. shCtrl, b P < 0.05 vs. shCTU2, c P < 0.05 vs . shCtrl + T0, * P < 0.05, ( n = 6); livers were photographed ( d ) and used to determine triglyceride (TG) content ( e ). * P < 0.05, ** P < 0.01, ns: not significant ( n = 4); tumor tissue was used to determine TG levels ( f ), Nile red staining ( g ), FASN immunofluorescent (IF) staining ( h ), and SREBP1, FASN, and ACC1 mRNA levels ( i ). * P < 0.05, ** P < 0.01, *** P < 0.001, ns: not significant, ( n = 4). Two-way ANOVA was performed

Article Snippet: Triglyceride content detection kit and Nile red staining kit was purchased from Solarbio (Beijing, China).

Techniques: Inhibition, Expressing, Injection, Staining